Free tool
Stocks above their 200-day average
We cover 468 companies trading above their own 200-day average. The median market value in the group is $704.00M. Across the group, the median move over the past trading day is −0.20%. 100% of the 468 with a 200-day average trade above it. Price change over the past year runs from −25.0% to +274.8% across the middle 80 percent of the group, with a median of +53.0%. Across the group, 5 companies currently carry a tier A volume signal.
Other lists in this group
Table
468 of 10,735 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| AVTR | Avantor, Inc. | $9.81B | Mid cap | +9.93% |
| PTGX | Protagonist Therapeutics, Inc. | $9.80B | Mid cap | +146.62% |
| NUVL | Nuvalent Inc | $9.79B | Mid cap | +62.83% |
| BIO-B | Bio-Rad Laboratories, Inc. | $9.77B | Mid cap | +47.78% |
| OSCR | Oscar Health, Inc. | $9.55B | Mid cap | +83.55% |
| TWST | Twist Bioscience Corporation | $9.41B | Mid cap | +451.89% |
| PCVX | Vaxcyte, Inc. | $9.09B | Mid cap | +99.97% |
| IMVT | Immunovant, Inc. | $9.07B | Mid cap | +189.13% |
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −9.65% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +179.08% |
| HQY | HealthEquity, Inc. | $8.75B | Mid cap | +18.69% |
| BRKR | Bruker Corporation | $8.69B | Mid cap | +70.56% |
| ATR | AptarGroup, Inc. | $8.60B | Mid cap | −1.89% |
| TGTX | TG Therapeutics, Inc. Common Stock | $8.42B | Mid cap | +92.61% |
| TXG | 10x Genomics, Inc. | $8.37B | Mid cap | +358.35% |
| ALKS | Alkermes plc | $8.25B | Mid cap | +68.07% |
| SYRE | Spyre Therapeutics, Inc. | $8.13B | Mid cap | +446.12% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $7.78B | Mid cap | +9.35% |
| CAI | Caris Life Sciences, Inc. | $7.58B | Mid cap | −29.83% |
| SRRK | Scholar Rock Holding Corporation | $7.31B | Mid cap | +74.18% |
| HNGE | Hinge Health, Inc. | $7.25B | Mid cap | +56.66% |
| CHE | Chemed Corporation | $7.11B | Mid cap | +20.79% |
| PACS | PACS Group, Inc. | $7.03B | Mid cap | +274.28% |
| HIMS | Hims & Hers Health, Inc. | $6.96B | Mid cap | −32.22% |
| CGON | CG Oncology, Inc. | $6.95B | Mid cap | +196.15% |
| ERAS | Erasca, Inc. | $6.70B | Mid cap | +1112.03% |
| LNTH | Lantheus Holdings, Inc. | $6.58B | Mid cap | +77.38% |
| ORKA | Oruka Therapeutics, Inc. | $6.58B | Mid cap | +555.07% |
| BLTE | Belite Bio, Inc | $6.31B | Mid cap | +144.07% |
| LQDA | Liquidia Corporation | $6.31B | Mid cap | +154.86% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | Mid cap | +143.24% |
| AMRX | Amneal Pharmaceuticals, Inc. | $6.27B | Mid cap | +92.20% |
| TVTX | Travere Therapeutics, Inc. | $6.24B | Mid cap | +284.86% |
| XENE | Xenon Pharmaceuticals Inc. | $6.18B | Mid cap | +64.11% |
| BLCO | Bausch + Lomb Corporation | $6.16B | Mid cap | +18.56% |
| DNTH | Dianthus Therapeutics, Inc. | $6.13B | Mid cap | +356.93% |
| STVN | Stevanato Group S.p.A. | $6.11B | Mid cap | −0.09% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $6.05B | Mid cap | +133.47% |
| RDNT | RadNet, Inc. | $6.05B | Mid cap | +7.27% |
| MIRM | Mirum Pharmaceuticals, Inc. | $5.98B | Mid cap | +31.96% |
| DFTX | Definium Therapeutics, Inc. | $5.88B | Mid cap | +344.37% |
| TFX | Teleflex Incorporated | $5.88B | Mid cap | +8.06% |
| LGND | Ligand Pharmaceuticals Incorporated | $5.74B | Mid cap | +80.92% |
| CRSP | CRISPR Therapeutics AG | $5.73B | Mid cap | +10.65% |
| SHC | Sotera Health Company | $5.58B | Mid cap | +18.42% |
| MMSI | Merit Medical Systems, Inc. | $5.44B | Mid cap | −0.28% |
| ACAD | ACADIA Pharmaceuticals Inc. | $5.07B | Mid cap | +11.33% |
| DYN | Dyne Therapeutics, Inc. | $4.92B | Mid cap | +93.26% |
| HAE | Haemonetics Corporation | $4.85B | Mid cap | +93.71% |
| EWTX | Edgewise Therapeutics, Inc. | $4.80B | Mid cap | +207.13% |
| LFST | LifeStance Health Group, Inc. | $4.69B | Mid cap | +121.31% |
| BLLN | BillionToOne, Inc. | $4.54B | Mid cap | −11.68% |
| ICUI | ICU Medical, Inc. | $4.49B | Mid cap | +41.83% |
| NVST | Envista Holdings Corporation | $4.47B | Mid cap | +30.89% |
| ELVN | Enliven Therapeutics, Inc. | $4.46B | Mid cap | +194.32% |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +50.93% |
| LIVN | LivaNova PLC | $4.41B | Mid cap | +41.56% |
| TNGX | Tango Therapeutics, Inc. | $4.29B | Mid cap | +269.13% |
| RLAY | Relay Therapeutics, Inc. | $4.26B | Mid cap | +445.10% |
| HTFL | Heartflow, Inc. | $4.26B | Mid cap | +40.79% |
| ITGR | Integer Holdings Corporation | $4.25B | Mid cap | +15.84% |
| INDV | Indivior Pharmaceuticals, Inc. | $4.23B | Mid cap | +47.06% |
| ADPT | Adaptive Biotechnologies Corporation | $4.18B | Mid cap | +101.70% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $4.13B | Mid cap | +292.38% |
| IDYA | IDEAYA Biosciences, Inc. | $4.01B | Mid cap | +66.32% |
| VKTX | Viking Therapeutics, Inc. | $4.01B | Mid cap | +29.15% |
| DNLI | Denali Therapeutics Inc. | $3.98B | Mid cap | +57.50% |
| ABCL | AbCellera Biologics Inc. | $3.97B | Mid cap | +181.38% |
| RCUS | Arcus Biosciences, Inc. | $3.92B | Mid cap | +191.29% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | Mid cap | +55.97% |
| TLX | Telix Pharmaceuticals Limited | $3.77B | Mid cap | −8.02% |
| IOVA | Iovance Biotherapeutics, Inc. | $3.66B | Mid cap | +233.88% |
| OGN | Organon & Co. | $3.62B | Mid cap | +50.67% |
| VCYT | Veracyte, Inc. Common Stock | $3.56B | Mid cap | +54.81% |
| GRAL | GRAIL, Inc. | $3.55B | Mid cap | +136.66% |
| QURE | uniQure N.V. | $3.53B | Mid cap | +223.49% |
| NHC | National HealthCare Corporation | $3.53B | Mid cap | +103.83% |
| PLSE | Pulse Biosciences, Inc. | $3.43B | Mid cap | +203.47% |
| IMNM | Immunome, Inc. | $3.34B | Mid cap | +188.94% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $3.30B | Mid cap | +281.97% |
| MBX | MBX Biosciences, Inc. | $3.22B | Mid cap | +366.53% |
| BEAM | Beam Therapeutics Inc. | $3.21B | Mid cap | +79.06% |
| CLDX | Celldex Therapeutics, Inc. | $3.19B | Mid cap | +79.51% |
| IRON | Disc Medicine, Inc. | $3.17B | Mid cap | +37.90% |
| WRBY | Warby Parker Inc. | $3.15B | Mid cap | −3.96% |
| TARS | Tarsus Pharmaceuticals, Inc. | $3.10B | Mid cap | +22.19% |
| ALMS | Alumis Inc. | $3.06B | Mid cap | +380.08% |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +73.50% |
| ZLAB | Zai Lab Limited | $2.92B | Mid cap | −20.06% |
| ACHC | Acadia Healthcare Company, Inc. | $2.85B | Mid cap | +37.81% |
| SLS | SELLAS Life Sciences Group, Inc. | $2.77B | Mid cap | +615.10% |
| NRIX | Nurix Therapeutics, Inc. | $2.77B | Mid cap | +179.69% |
| VRDN | Viridian Therapeutics, Inc. | $2.75B | Mid cap | +30.71% |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +61.71% |
| WGS | GeneDx Holdings Corp. | $2.69B | Mid cap | −30.11% |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +219.58% |
| PGEN | Precigen, Inc. | $2.65B | Mid cap | +61.66% |
| CDNA | CareDx, Inc. | $2.64B | Mid cap | +283.45% |
| RARE | Ultragenyx Pharmaceutical Inc. | $2.61B | Mid cap | −12.10% |
| PHVS | Pharvaris N.V. | $2.60B | Mid cap | +55.59% |
| BHVN | Biohaven Ltd. | $2.56B | Mid cap | +8.65% |
| TRVI | Trevi Therapeutics, Inc. | $2.55B | Mid cap | +124.00% |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +103.83% |
| RAPP | Rapport Therapeutics, Inc. | $2.52B | Mid cap | +250.70% |
| NKTR | Nektar Therapeutics | $2.52B | Mid cap | +151.95% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $2.51B | Mid cap | +15.38% |
| KOD | Kodiak Sciences Inc. | $2.48B | Mid cap | +321.09% |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% |
| NUVB | Nuvation Bio Inc. | $2.44B | Mid cap | +135.93% |
| BHC | Bausch Health Companies Inc. | $2.43B | Mid cap | −10.45% |
| OCUL | Ocular Therapeutix, Inc. | $2.37B | Mid cap | −12.58% |
| GRDN | Guardian Pharmacy Services, Inc. | $2.36B | Mid cap | +45.50% |
| UFPT | UFP Technologies, Inc. | $2.36B | Mid cap | +41.94% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.31B | Mid cap | +4.23% |
| BFLY | Butterfly Network, Inc. | $2.30B | Mid cap | +450.32% |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +145.34% |
| NBTX | Nanobiotix S.A. | $2.26B | Mid cap | +394.99% |
| CLOV | Clover Health Investments, Corp. | $2.26B | Mid cap | +57.99% |
| ADUS | Addus HomeCare Corporation | $2.25B | Mid cap | +4.50% |
| URGN | UroGen Pharma Ltd. | $2.25B | Mid cap | +135.11% |
| MESO | Mesoblast Limited | $2.23B | Mid cap | +4.47% |
| PVLA | Palvella Therapeutics, Inc. | $2.22B | Mid cap | +173.39% |
| AUPH | Aurinia Pharmaceuticals Inc. | $2.20B | Mid cap | +36.58% |
| MD | Pediatrix Medical Group, Inc. | $2.19B | Mid cap | +56.87% |
| VCEL | Vericel Corporation | $2.17B | Mid cap | +18.25% |
| ZBIO | Zenas BioPharma, Inc. | $2.15B | Mid cap | +97.73% |
| STOK | Stoke Therapeutics, Inc. | $2.14B | Mid cap | +71.45% |
| XNCR | Xencor, Inc. Common Stock | $2.11B | Mid cap | +254.61% |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +96.28% |
| NVCR | NovoCure Limited | $2.08B | Mid cap | +50.21% |
| SRPT | Sarepta Therapeutics, Inc. | $2.06B | Mid cap | +7.69% |
| PRGO | Perrigo Company plc | $2.05B | Mid cap | −36.05% |
| SEM | Select Medical Holdings Corp | $2.05B | Mid cap | +28.14% |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | $2.03B | Mid cap | −13.45% |
| CMPS | COMPASS Pathways plc | $2.02B | Mid cap | +209.53% |
| GHRS | GH Research PLC | $1.99B | Small cap | +112.84% |
| PIII | P3 Health Partners Inc. | $1.98B | Small cap | +26.37% |
| PGNY | Progyny, Inc. | $1.98B | Small cap | +14.55% |
| TSHA | Taysha Gene Therapies, Inc. | $1.96B | Small cap | +102.69% |
| IMCR | Immunocore Holdings plc | $1.93B | Small cap | +13.69% |
| ASTH | Astrana Health, Inc. | $1.92B | Small cap | +23.71% |
| SNDA | Sonida Senior Living, Inc. | $1.91B | Small cap | +51.53% |
| NTLA | Intellia Therapeutics, Inc. | $1.89B | Small cap | +15.50% |
| DMRA | Damora Therapeutics, Inc. | $1.89B | Small cap | +804.46% |
| SEPN | Septerna, Inc. | $1.88B | Small cap | +218.81% |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +111.85% |
| PSNL | Personalis, Inc. | $1.82B | Small cap | +257.32% |
| BLFS | BioLife Solutions, Inc. | $1.82B | Small cap | +45.50% |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +357.45% |
| ETON | Eton Pharmaceuticals, Inc. | $1.79B | Small cap | +262.38% |
| FTRE | Fortrea Holdings Inc. | $1.76B | Small cap | +105.20% |
| ALVO | Alvotech | $1.75B | Small cap | −38.85% |
| ANAB | AnaptysBio, Inc. | $1.73B | Small cap | +326.47% |
| BCAX | Bicara Therapeutics Inc. | $1.64B | Small cap | +105.74% |
| FBRX | Forte Biosciences, Inc. | $1.63B | Small cap | +589.87% |
| AGL | agilon health, inc. | $1.61B | Small cap | +194.58% |
| ARDT | Ardent Health, Inc. | $1.58B | Small cap | −11.64% |
| XERS | Xeris Biopharma Holdings, Inc. | $1.58B | Small cap | +8.64% |
| ABSI | Absci Corporation | $1.58B | Small cap | +261.57% |
| HCSG | Healthcare Services Group, Inc. | $1.57B | Small cap | +47.05% |
| KMTS | Kestra Medical Technologies, Ltd. | $1.56B | Small cap | +47.61% |
| LBRX | LB Pharmaceuticals Inc | $1.55B | Small cap | +178.41% |
| AVBP | ArriVent BioPharma, Inc. | $1.54B | Small cap | +62.10% |
| CNMD | CONMED Corporation | $1.53B | Small cap | −6.91% |
| NVAX | Novavax, Inc. | $1.52B | Small cap | +21.50% |
| REPL | Replimune Group, Inc. | $1.50B | Small cap | +187.16% |
| TNDM | Tandem Diabetes Care, Inc. Common Stock | $1.49B | Small cap | +74.45% |
| INNV | InnovAge Holding Corp. | $1.48B | Small cap | +178.79% |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +188.15% |
| AZTA | Azenta, Inc. | $1.47B | Small cap | +11.16% |
| OMDA | Omada Health, Inc. | $1.47B | Small cap | +2.74% |
| SDGR | Schrödinger, Inc. | $1.46B | Small cap | −1.62% |
| ENOV | Enovis Corporation | $1.46B | Small cap | −18.60% |
| ORIC | ORIC Pharmaceuticals, Inc. | $1.44B | Small cap | +35.58% |
| KALV | KalVista Pharmaceuticals Inc | $1.44B | Small cap | +98.68% |
| ANRO | Alto Neuroscience, Inc. | $1.43B | Small cap | +786.65% |
| MGTX | MeiraGTx Holdings plc | $1.43B | Small cap | +100.54% |
| OMER | Omeros Corporation | $1.40B | Small cap | +328.71% |
| JBIO | Jade Biosciences, Inc. | $1.39B | Small cap | +168.30% |
| DRTS | Alpha Tau Medical Ltd. | $1.38B | Small cap | +343.92% |
| NUTX | Nutex Health Inc. | $1.34B | Small cap | +118.22% |
| PNTG | The Pennant Group, Inc. | $1.34B | Small cap | +56.31% |
| AMN | AMN Healthcare Services, Inc. | $1.33B | Small cap | +70.26% |
| CRON | Cronos Group Inc. | $1.31B | Small cap | +38.67% |
| IART | Integra LifeSciences Holdings Corporation | $1.31B | Small cap | +13.52% |
| VOR | Vor Biopharma Inc. | $1.30B | Small cap | −40.82% |
| SANA | Sana Biotechnology, Inc. | $1.25B | Small cap | +23.44% |
| GDRX | GoodRx Holdings, Inc. | $1.25B | Small cap | −18.89% |
| CERT | Certara, Inc. | $1.24B | Small cap | −25.07% |
| CRVS | Corvus Pharmaceuticals, Inc. | $1.22B | Small cap | +167.82% |
| AVNS | Avanos Medical Inc | $1.17B | Small cap | +110.53% |
| USPH | U.S. Physical Therapy, Inc. | $1.17B | Small cap | −5.67% |
| KURA | Kura Oncology, Inc. | $1.16B | Small cap | +66.16% |
| JANX | Janux Therapeutics, Inc. | $1.15B | Small cap | −19.10% |
| SVRA | Savara Inc. | $1.15B | Small cap | +70.52% |
| OPK | OPKO Health, Inc. | $1.11B | Small cap | +6.34% |
| AVTX | Avalo Therapeutics, Inc. | $1.10B | Small cap | +112.95% |
| SLDB | Solid Biosciences Inc. | $1.04B | Small cap | +72.95% |
| LXRX | Lexicon Pharmaceuticals, Inc. | $1.04B | Small cap | +104.42% |
| CSTL | Castle Biosciences, Inc. | $1.04B | Small cap | +52.96% |
| ABUS | Arbutus Biopharma Corporation | $1.03B | Small cap | +42.19% |
| PCRX | Pacira BioSciences, Inc. | $1.02B | Small cap | −0.88% |
| CADL | Candel Therapeutics, Inc. | $1.02B | Small cap | +124.70% |
| IMMX | Immix Biopharma, Inc. | $1.00B | Small cap | +617.86% |
| GERN | Geron Corporation | $995.83M | Small cap | +8.51% |
| HELP | Cybin D/B/A Helus Pharma | $995.81M | Small cap | +77.71% |
| DSGN | Design Therapeutics, Inc. | $975.65M | Small cap | +194.71% |
| BVS | Bioventus Inc. | $954.22M | Small cap | +86.52% |
| CLYM | Climb Bio Inc | $923.57M | Small cap | +603.72% |
| ACRS | Aclaris Therapeutics, Inc. | $911.16M | Small cap | +240.11% |
| CBLL | CeriBell, Inc. | $899.97M | Small cap | +102.16% |
| ANL | Adlai Nortye Ltd. | $884.83M | Small cap | +791.12% |
| TALK | Talkspace, Inc. | $870.57M | Small cap | +93.73% |
| BBNX | Beta Bionics, Inc. | $870.10M | Small cap | +1.95% |
| AVR | Anteris Technologies Global Corp. | $865.37M | Small cap | +144.54% |
| RIGL | Rigel Pharmaceuticals, Inc. | $864.97M | Small cap | +16.99% |
| INMD | InMode Ltd. | $864.89M | Small cap | −1.71% |
| SIBN | SI-BONE, Inc. | $861.71M | Small cap | +17.12% |
| FDMT | 4D Molecular Therapeutics, Inc. | $859.60M | Small cap | +140.87% |
| ACHV | Achieve Life Sciences, Inc. | $851.00M | Small cap | +177.52% |
| SLN | Silence Therapeutics plc | $840.94M | Small cap | +160.19% |
| HSTM | HealthStream, Inc. | $840.94M | Small cap | +1.86% |
| ESPR | Esperion Therapeutics, Inc. Common Stock | $819.46M | Small cap | +45.87% |
| NVCT | Nuvectis Pharma, Inc. | $816.10M | Small cap | +275.94% |
| AURA | Aura Biosciences, Inc. | $801.64M | Small cap | +20.03% |
| STTK | Shattuck Labs, Inc. | $792.87M | Small cap | +690.00% |
| VREX | Varex Imaging Corporation | $778.90M | Small cap | +61.40% |
| NGNE | Neurogene Inc. | $768.64M | Small cap | +95.02% |
| MNPR | Monopar Therapeutics Inc. | $763.31M | Small cap | +226.69% |
| SOPH | SOPHiA GENETICS SA | $726.14M | Small cap | +156.16% |
| ASMB | Assembly Biosciences, Inc. | $721.17M | Small cap | +36.81% |
| XOMA | XOMA Royalty Corp | $710.16M | Small cap | +19.27% |
| IRWD | Ironwood Pharmaceuticals, Inc. | $708.88M | Small cap | +240.48% |
| ALLO | Allogene Therapeutics, Inc. | $704.80M | Small cap | +75.86% |
| TECX | Tectonic Therapeutic, Inc. | $703.19M | Small cap | +35.43% |
| OABI | OmniAb, Inc. | $699.33M | Small cap | +198.76% |
| ZVRA | Zevra Therapeutics, Inc. | $697.17M | Small cap | +25.43% |
| AQST | Aquestive Therapeutics, Inc. | $676.51M | Small cap | +40.00% |
| SGMT | Sagimet Biosciences Inc. | $675.04M | Small cap | +39.59% |
| CBIO | Crescent Biopharma, Inc. | $669.39M | Small cap | +26.46% |
| CRMD | CorMedix Inc. | $653.95M | Small cap | −40.66% |
| PRME | Prime Medicine, Inc. | $649.33M | Small cap | +4.37% |
| ANGO | AngioDynamics, Inc. | $648.51M | Small cap | +56.74% |
| VSTM | Verastem, Inc. | $641.19M | Small cap | −20.45% |
| CTNM | Contineum Therapeutics, Inc. | $640.31M | Small cap | +70.03% |
| KIDS | OrthoPediatrics Corp. | $639.69M | Small cap | +11.10% |
| CTEV | Claritev Corporation | $636.72M | Small cap | −47.71% |
| AUTL | Autolus Therapeutics plc | $620.16M | Small cap | +48.41% |
| WEAV | Weave Communications, Inc. | $584.79M | Small cap | −5.68% |
| EOLS | Evolus, Inc. | $579.92M | Small cap | +15.83% |
| ARTV | Artiva Biotherapeutics, Inc. | $575.44M | Small cap | +259.94% |
| BWAY | BrainsWay Ltd. | $574.70M | Small cap | +87.42% |
| ZURA | Zura Bio Limited | $574.02M | Small cap | +177.31% |
| DCTH | Delcath Systems, Inc. | $569.06M | Small cap | +49.91% |
| OVID | Ovid Therapeutics Inc. | $562.46M | Small cap | +128.57% |
| EVH | Evolent Health, Inc. | $556.25M | Small cap | −48.86% |
| ENTX | Entera Bio Ltd. | $552.32M | Small cap | +62.76% |
| CERS | Cerus Corporation | $552.18M | Small cap | +109.16% |
| KYTX | Kyverna Therapeutics, Inc. | $546.70M | Small cap | +133.33% |
| CABA | Cabaletta Bio, Inc. | $545.94M | Small cap | +116.67% |
| SRTA | Strata Critical Medical, Inc. | $541.42M | Small cap | +33.62% |
| PRLD | Prelude Therapeutics Incorporated | $522.47M | Small cap | +412.50% |
| CCCC | C4 Therapeutics, Inc. | $521.63M | Small cap | +64.34% |
| TOI | Starling Oncology Inc | $512.91M | Small cap | +79.19% |
| CLPT | ClearPoint Neuro, Inc. | $499.35M | Small cap | +53.85% |
| SENS | Senseonics Holdings, Inc. | $493.84M | Small cap | +0.43% |
| EPRX | Eupraxia Pharmaceuticals Inc. | $490.26M | Small cap | +40.72% |
| EDIT | Editas Medicine, Inc. | $488.38M | Small cap | +19.10% |
| NRC | NRC Health | $487.06M | Small cap | +45.92% |
| RZLT | Rezolute, Inc. | $485.31M | Small cap | −30.00% |
| KMDA | Kamada Ltd. Ordinary Shares | $483.48M | Small cap | +21.09% |
| QTTB | Q32 Bio Inc. | $481.67M | Small cap | +840.70% |
| PBYI | Puma Biotechnology, Inc. | $472.84M | Small cap | +79.61% |
| SGHT | Sight Sciences, Inc. | $458.33M | Small cap | +97.87% |
| ARCT | Arcturus Therapeutics Holdings Inc. | $449.94M | Small cap | −8.44% |
| MCTA | Charming Medical Limited | $445.55M | Small cap | +319.36% |
| BNTC | Benitec Biopharma Inc. | $442.48M | Small cap | +0.16% |
| AVIR | Atea Pharmaceuticals, Inc. | $441.93M | Small cap | +53.06% |
| CARL | Carlsmed, Inc. | $441.76M | Small cap | +16.40% |
| LRMR | Larimar Therapeutics, Inc. | $432.15M | Small cap | +6.92% |
| MASS | 908 Devices Inc. | $428.63M | Small cap | +64.60% |
| CCRN | Cross Country Healthcare Inc | $428.06M | Small cap | +0.38% |
| FENC | Fennec Pharmaceuticals Inc. | $426.77M | Small cap | +34.62% |
| GALT | Galectin Therapeutics Inc. | $418.53M | Small cap | +4.27% |
| XFOR | X4 Pharmaceuticals, Inc. | $412.45M | Small cap | −1.42% |
| ENTA | Enanta Pharmaceuticals, Inc. | $412.12M | Small cap | +65.89% |
| RCKT | Rocket Pharmaceuticals, Inc. | $401.78M | Small cap | +10.24% |
| FHTX | Foghorn Therapeutics Inc. | $397.29M | Small cap | +23.66% |
| TBRG | TruBridge Inc | $393.58M | Small cap | +30.42% |
| IPSC | Century Therapeutics, Inc. | $392.93M | Small cap | +315.53% |
| TKNO | Alpha Teknova, Inc. | $387.63M | Small cap | +62.25% |
| AUNA | Auna SA | $387.31M | Small cap | −16.85% |
| SLP | Simulations Plus, Inc. | $372.34M | Small cap | +28.20% |
| AGEN | Agenus Inc. | $371.33M | Small cap | +81.72% |
| PALI | Palisade Bio, Inc. | $371.20M | Small cap | +222.73% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $368.27M | Small cap | +113.74% |
| IFRX | InflaRx N.V. | $356.63M | Small cap | +142.00% |
| VMD | Viemed Healthcare, Inc. | $355.36M | Small cap | +29.94% |
| SABS | SAB Biotherapeutics, Inc. | $353.03M | Small cap | +83.02% |
| IKT | Inhibikase Therapeutics, Inc. | $347.44M | Small cap | +39.11% |
| ABEO | Abeona Therapeutics Inc. | $343.68M | Small cap | −12.90% |
| PRQR | ProQR Therapeutics N.V. | $331.63M | Small cap | +6.33% |
| RCEL | AVITA Medical, Inc. | $327.52M | Small cap | +133.77% |
| SMTI | Sanara MedTech Inc. | $318.55M | Small cap | +2.09% |
| OBIO | Orchestra BioMed Holdings, Inc. | $316.15M | Small cap | +85.21% |
| IRD | Opus Genetics, Inc. | $316.14M | Small cap | +216.67% |
| RNAC | Cartesian Therapeutics, Inc. | $308.30M | Small cap | −4.09% |
| TMCI | Treace Medical Concepts, Inc. | $306.96M | Small cap | −36.39% |
| FATE | Fate Therapeutics, Inc. Common Stock | $305.54M | Small cap | +129.46% |
| TLSI | TriSalus Life Sciences, Inc. | $303.56M | Small cap | −3.33% |
| BDSX | Biodesix, Inc. | $296.22M | Small cap | +225.53% |
| TTRX | Turn Therapeutics Inc. | $292.44M | Small cap | +37.57% |
| ANIK | Anika Therapeutics, Inc. | $290.14M | Small cap | +136.17% |
| PYXS | Pyxis Oncology, Inc. | $278.58M | Small cap | +145.59% |
| WHWK | Whitehawk Therapeutics, Inc. | $275.92M | Small cap | +167.40% |
| ALXO | ALX Oncology Holdings Inc. | $273.79M | Small cap | +65.00% |
| ELDN | Eledon Pharmaceuticals, Inc. | $272.22M | Small cap | +29.84% |
| CGEN | Compugen Ltd. | $271.86M | Small cap | +93.20% |
| ELMD | Electromed, Inc. | $265.79M | Small cap | +28.26% |
| ALEC | Alector, Inc. | $263.51M | Small cap | +2.50% |
| SLGL | Sol-Gel Technologies Ltd. | $260.05M | Small cap | +261.87% |
| PROF | Profound Medical Corp. | $259.75M | Small cap | +57.30% |
| NERV | Minerva Neurosciences, Inc. | $259.27M | Small cap | +129.11% |
| ADAG | Adagene Inc. | $258.50M | Small cap | +75.80% |
| MGNX | MacroGenics, Inc. Common Stock | $257.35M | Small cap | +134.88% |
| OSUR | OraSure Technologies, Inc. | $255.87M | Small cap | +11.08% |
| IPHA | Innate Pharma S.A. | $253.56M | Small cap | +2.86% |
| ACB | Aurora Cannabis Inc. | $253.24M | Small cap | −24.95% |
| CRDL | Cardiol Therapeutics Inc. | $250.00M | Small cap | +91.07% |
| DTIL | Precision BioSciences, Inc. | $234.34M | Small cap | +69.46% |
| STIM | Neuronetics, Inc. | $227.07M | Small cap | −10.71% |
| UTMD | Utah Medical Products, Inc. | $225.70M | Small cap | +17.76% |
| IMUX | Immunic, Inc. | $225.00M | Small cap | +92.87% |
| HITI | High Tide Inc. | $221.43M | Small cap | −30.00% |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $218.56M | Small cap | +7.93% |
| ORMP | Oramed Pharmaceuticals Inc. | $218.55M | Small cap | +159.19% |
| ABOS | Acumen Pharmaceuticals, Inc. | $216.23M | Small cap | +115.11% |
| DERM | Journey Medical Corporation | $212.95M | Small cap | +0.87% |
| CUE | Cue Biopharma, Inc. | $209.58M | Small cap | +16.42% |
| ANTX | AN2 Therapeutics, Inc. | $208.68M | Small cap | +385.09% |
| ACOG | Alpha Cognition Inc. | $204.93M | Small cap | +14.20% |
| PDEX | Pro-Dex, Inc. | $203.83M | Small cap | +40.31% |
| KRRO | Korro Bio, Inc. | $201.45M | Small cap | −36.61% |
| PLX | Protalix BioTherapeutics, Inc. | $199.82M | Small cap | +55.00% |
| AMWL | American Well Corporation | $199.17M | Small cap | +71.51% |
| MSLE | Satellos Bioscience Inc. | $198.59M | Small cap | +77.27% |
| NKTX | Nkarta, Inc. | $194.10M | Small cap | +17.41% |
| XGN | Exagen Inc. | $185.81M | Small cap | −19.69% |
| MOLN | Molecular Partners AG | $170.46M | Small cap | +18.67% |
| KZIA | Kazia Therapeutics Limited | $166.83M | Small cap | +86.94% |
| FOCL | EDAP TMS S.A. | $164.75M | Small cap | +179.11% |
| OKUR | OnKure Therapeutics, Inc. | $155.52M | Small cap | +35.71% |
| ASRT | Assertio Holdings Inc | $151.86M | Small cap | +103.46% |
| NRXP | NRx Pharmaceuticals, Inc. | $149.80M | Small cap | +34.11% |
| EQ | Equillium, Inc. | $149.64M | Small cap | +23.56% |
| MXCT | MaxCyte, Inc. | $139.33M | Small cap | −6.43% |
| HURA | TuHURA Biosciences, Inc. | $135.74M | Small cap | −26.55% |
| CPIX | Cumberland Pharmaceuticals Inc. | $130.35M | Small cap | +163.82% |
| PMN | ProMIS Neurosciences, Inc. | $129.67M | Small cap | +9.13% |
| VANI | Vivani Medical, Inc. | $127.64M | Small cap | +15.98% |
| BMEA | Biomea Fusion, Inc. | $123.95M | Small cap | −8.06% |
| ANIX | Anixa Biosciences, Inc. | $122.65M | Small cap | +22.20% |
| QUCY | Quantum Cyber N.V. | $115.59M | Small cap | −15.12% |
| SEER | Seer, Inc. | $112.96M | Small cap | −1.94% |
| LNSR | LENSAR, Inc. | $106.27M | Small cap | −29.04% |
| LUNG | Pulmonx Corporation | $105.59M | Small cap | +34.41% |
| PYPD | PolyPid Ltd. | $103.79M | Small cap | +49.42% |
| PTHS | Pelthos Therapeutics Inc. | $102.53M | Small cap | +12.90% |
| ATRA | Atara Biotherapeutics, Inc. | $94.15M | Micro cap | −24.05% |
| ACRV | Acrivon Therapeutics, Inc. | $93.42M | Micro cap | +52.94% |
| ECOR | electroCore, Inc. | $93.31M | Micro cap | +86.49% |
| ICCC | ImmuCell Corporation | $91.00M | Micro cap | +64.26% |
| RLYB | Rallybio Corporation | $89.64M | Micro cap | +257.63% |
| ATHE | Alterity Therapeutics Limited | $86.64M | Micro cap | −4.40% |
| CING | Cingulate Inc. | $85.36M | Micro cap | +29.19% |
| ACET | Adicet Bio, Inc. | $83.79M | Micro cap | −26.01% |
| APLM | Apollomics, Inc. | $76.75M | Micro cap | +320.55% |
| OSTX | OS Therapies Incorporated | $76.68M | Micro cap | −34.00% |
| LONA | LeonaBio, Inc. | $75.47M | Micro cap | +95.25% |
| NRXS | NeurAxis, Inc. | $74.84M | Micro cap | +146.28% |
| MNOV | MediciNova, Inc. | $72.85M | Micro cap | +10.45% |
| FBIOP | Fortress Biotech, Inc. | $71.45M | Micro cap | +131.74% |
| PMVP | PMV Pharmaceuticals, Inc. | $70.03M | Micro cap | −7.75% |
| INCR | InterCure Ltd. | $69.65M | Micro cap | +265.03% |
| INMB | INmune Bio Inc. | $67.86M | Micro cap | +19.56% |
| RNXT | RenovoRx, Inc. | $67.24M | Micro cap | +61.08% |
| SER | Serina Therapeutics, Inc. | $66.80M | Micro cap | −47.29% |
| BOLD | Boundless Bio, Inc. | $66.31M | Micro cap | +155.70% |
| TLPH | Talphera, Inc. | $65.40M | Micro cap | +133.33% |
| MYO | Myomo, Inc. | $60.60M | Micro cap | +36.61% |
| INKT | MiNK Therapeutics, Inc. | $60.16M | Micro cap | −26.22% |
| XLO | Xilio Therapeutics, Inc. | $59.55M | Micro cap | −5.63% |
| COCH | Envoy Medical, Inc. | $56.82M | Micro cap | −37.09% |
| SCYX | SCYNEXIS, Inc. | $56.41M | Micro cap | +579.04% |
| NTRB | Nutriband Inc. | $54.70M | Micro cap | −29.80% |
| PRPO | Precipio, Inc. | $54.43M | Micro cap | +99.25% |
| HOWL | Werewolf Therapeutics, Inc. | $48.05M | Micro cap | −25.65% |
| MLSS | Milestone Scientific Inc. | $47.87M | Micro cap | −10.10% |
| ALGS | Aligos Therapeutics, Inc. | $46.65M | Micro cap | −33.72% |
| ELUT | Elutia Inc. | $44.29M | Micro cap | −54.75% |
| NEPH | Nephros, Inc. | $43.98M | Micro cap | 0.00% |
| HBIO | Harvard Bioscience, Inc. | $34.83M | Micro cap | +44.34% |
| CCEL | Cryo-Cell International, Inc. | $34.67M | Micro cap | −3.19% |
| NSYS | Nortech Systems Incorporated | $33.62M | Micro cap | +30.74% |
| KYNB | Kyntra Bio, Inc. | $32.82M | Micro cap | −22.66% |
| RMTI | Rockwell Medical, Inc. | $31.90M | Micro cap | +438.44% |
| QNCX | Quince Therapeutics, Inc. | $31.84M | Micro cap | +100.71% |
| IGC | IGC Pharma, Inc. | $31.49M | Micro cap | −31.62% |
| BRNS | Barinthus Biotherapeutics plc | $28.86M | Micro cap | −38.04% |
| GRDX | GridAI Technologies Corp. | $28.75M | Micro cap | +111.52% |
| TXMD | TherapeuticsMD, Inc. | $26.39M | Micro cap | +103.57% |
| MRKR | Marker Therapeutics, Inc. | $24.18M | Micro cap | +54.26% |
| FEMY | Femasys Inc. | $23.87M | Micro cap | +711.11% |
| BFRI | Biofrontera Inc. | $22.72M | Micro cap | +77.91% |
| RVP | Retractable Technologies, Inc. | $21.85M | Micro cap | −12.05% |
| COCP | Cocrystal Pharma, Inc. | $21.57M | Micro cap | −27.74% |
| CCM | Concord Medical Services Holdings Limited | $21.49M | Micro cap | −10.47% |
| ALLR | Allarity Therapeutics, Inc. | $21.32M | Micro cap | −15.72% |
| LFWD | Lifeward Ltd. | $20.93M | Micro cap | +0.03% |
| PMI | Picard Medical, Inc. | $20.13M | Micro cap | +113.51% |
| NCEL | NewcelX Ltd. | $19.52M | Micro cap | −84.77% |
| VYNE | VYNE Therapeutics Inc | $19.07M | Micro cap | +8660.74% |
| LEXX | Lexaria Bioscience Corp. | $18.24M | Micro cap | +1146.05% |
| BCDA | BioCardia, Inc. | $18.02M | Micro cap | −38.66% |
| CYCN | Cyclerion Therapeutics, Inc. | $17.97M | Micro cap | +61.48% |
| BIVI | BioVie Inc. | $17.83M | Micro cap | +30.25% |
| ADIL | Adial Pharmaceuticals, Inc. | $17.43M | Micro cap | −37.47% |
| CMMB | Chemomab Therapeutics Ltd. | $16.85M | Micro cap | −25.57% |
| ADVB | Advanced Biomed Inc. | $15.27M | Micro cap | +13.24% |
| PHIO | Phio Pharmaceuticals Corp. | $13.94M | Micro cap | −40.89% |
| HSCS | HeartSciences Inc. | $13.47M | Micro cap | −11.54% |
| APRE | Aprea Therapeutics, Inc. | $12.34M | Micro cap | −38.75% |
| ASBP | Aspire Biopharma Holdings, Inc. | $11.68M | Micro cap | −60.93% |
| KPRX | Kiora Pharmaceuticals, Inc. | $11.46M | Micro cap | −9.44% |
| TOVX | Theriva Biologics, Inc. | $11.16M | Micro cap | −42.10% |
| LUCY | Lucyd, Inc | $9.73M | Micro cap | −42.05% |
| MBAI | Check-Cap Ltd. | $9.33M | Micro cap | +943.08% |
| BMGL | Basel Medical Group Ltd | $9.29M | Micro cap | +202.81% |
| IMRN | Immuron Limited | $9.20M | Micro cap | −35.77% |
| XBIO | Xenetic Biosciences, Inc. | $9.04M | Micro cap | +35.92% |
| SKYE | Skye Bioscience, Inc. | $8.92M | Micro cap | −41.62% |
| XWEL | XWELL, Inc. | $8.55M | Micro cap | −6.93% |
| CNSP | CNS Pharmaceuticals, Inc. | $8.48M | Micro cap | −13.51% |
| NDRA | ENDRA Life Sciences Inc. | $8.16M | Micro cap | +32.36% |
| ALZN | Alzamend Neuro, Inc. | $8.06M | Micro cap | −32.11% |
| NVNO | enVVeno Medical Corporation | $7.97M | Micro cap | −63.76% |
| ICCM | IceCure Medical Ltd | $7.85M | Micro cap | +132.49% |
| TRIB | Trinity Biotech plc | $7.80M | Micro cap | +547.97% |
| INM | InMed Pharmaceuticals Inc. | $7.64M | Micro cap | −36.44% |
| CURX | Curanex Pharmaceuticals Inc | $7.21M | Micro cap | −1.29% |
| JUNS | Jupiter Neurosciences, Inc. | $6.66M | Micro cap | +236.24% |
| AMIX | Autonomix Medical, Inc. | $6.20M | Micro cap | +440.68% |
| LIMN | Liminatus Pharma, Inc. | $6.19M | Micro cap | +46.03% |
| HCWB | HCW Biologics Inc. | $4.96M | Micro cap | −55.15% |
| XAIR | Beyond Air, Inc. | $4.89M | Micro cap | +117.98% |
| GLMD | Galmed Pharmaceuticals Ltd. | $4.48M | Micro cap | +211.51% |
| SILO | Silo Pharma, Inc. | $4.38M | Micro cap | +290.62% |
| UPC | Universe Pharmaceuticals INC | $3.53M | Micro cap | +44.57% |
| CLDI | Calidi Biotherapeutics, Inc. | $3.49M | Micro cap | −19.16% |
| TNON | Tenon Medical, Inc. | $3.48M | Micro cap | +297.71% |
| GNPX | Genprex, Inc. | $3.25M | Micro cap | −54.10% |
| BIAF | bioAffinity Technologies, Inc. | $3.02M | Micro cap | −31.59% |
| PFSA | Profusa, Inc. | $2.58M | Micro cap | −86.13% |
| VRAX | Virax Biolabs Group Limited | $2.21M | Micro cap | +365.55% |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. | $2.10M | Micro cap | +7.65% |
| MNDR | Mobile-health Network Solutions | $1.92M | Micro cap | −69.91% |
| SCNI | Scinai Immunotherapeutics Ltd. | $1.48M | Micro cap | +93.92% |
| APM | Aptorum Group Ltd | $570.06K | Micro cap | +273.78% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.